Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial

Fig. 2

Kaplan-Meier curves for the cumulative probability of freedom from CMV disease (a), CMV DNAemia (b), biopsy-proven acute rejection (c), and polyoma BK virus viremia (d). The Cox proportional hazard model adjusting for calcineurin inhibitor, induction therapy, and advanced chronic histologic damage in donor biopsy. aHR adjusted hazard ratio, CI confidence interval

Back to article page